#vaccines #immunisations #CHMP #GSK #RSVvaccine #respiratorysyncytialvirus #respiratorysyncytialvirusvaccine #RSV #Arexvy #labelexpansion #CHMPrecommendation #Pfizer #Abrysvo #Moderna #mResvia #lowerrespiratorytractdisease #LRTD #RSVdisease #RSVinfections #infectiousdiseases
zurl.co/PkV03
zurl.co/PkV03
CHMP decision levels the playing field for GSK's RSV jab
GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.
pharmaphorum.com
December 17, 2025 at 11:47 AM